[Experience with and considerations on therapy of progressive muscular dystrophies].
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000596:Amino Acids / Q000627:therapeutic use; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004035:Diet Therapy; D004074:Digitoxin / Q000009:adverse effects*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009132:Muscles / Q000378:metabolism; D009136:Muscular Dystrophies / Q000145:classification / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D010710:Phosphates / Q000627:therapeutic use*; D026741:Physical Therapy Modalities; D011613:Psychotherapy; D014451:Ubiquinone / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use
D000596:Amino Acids; D045930:Anabolic Agents; D005938:Glucocorticoids; D007328:Insulin; D010710:Phosphates; D014815:Vitamins; D014451:Ubiquinone; D014810:Vitamin E; D000255:Adenosine Triphosphate; D004074:Digitoxin
Erfahrungen und Vorstellungen zur Therapie der progressiven Muskeldystrophien.